John Leonard - Articles and news items

Abbott logo
Abbott logo

Abbott receives positive opinion for HUMIRA® in non-radiographic axial spondyloarthritis from EMA’s CHMP

Industry news, News / 25 June 2012 / Abbott

Abbott announced that the CHMP has issued a positive opinion for HUMIRA®…

Abbott logo
Abbott logo

Abbott and Galapagos announce global collaboration for novel oral therapy, GLPG0634, in Phase II

Industry news, News / 29 February 2012 / Abbott

Abbott and Galapagos have entered into a global collaboration…

Abbott logo

Abbott receives positive opinion for HUMIRA® in Ulcerative Colitis from EMA’s CHMP

Industry news, News / 17 February 2012 / Abbott

Positive opinion based on supporting data from two Phase III clinical studies…

Abbott logo

DNDi and Abbott expand partnership to boost innovation for neglected tropical diseases

Industry news, News / 30 January 2012 / Abbott

DNDi & Abbott have signed a four-year joint research & non-exclusive licensing agreement…

Abbott logo

Abbott and Reata Pharmaceuticals announce agreement to develop and commercialize next-generation AIMs

Industry news, News / 12 December 2011 / Abbott

Agreement calls for 50/50 global profit share for multiple new molecules…

Abbott logo

Abbott statement on the results of the AIM-HIGH study presented at AHA 2011

Industry news, News / 15 November 2011 / Abbott

Final results were presented today from the AIM-HIGH study, a National Heart, Lung and Blood Institute (NHLBI) study…

Abbott logo

Abbott presents HUMIRA® (adalimumab) Phase 3 study results

Industry news, News / 7 November 2011 / Abbott

In ABILITY-1 Study Presented at ACR, More than Twice as Many Patients Treated with HUMIRA Met Primary Endpoint Compared to Placebo…

Abbott logo


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...